COCH (Envoy Medical) 5-Year Yield-on-Cost %: 0.00 (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COCH Envoy Medical Inc COCH
6 GF Score
Price $0.67
GF Value $0.81
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Envoy Medical 5-Year Yield-on-Cost %?

Envoy Medical COCH -1.00% 6 5-Year Yield-on-Cost % is 0.00 as of Aug. 09, 2026. GuruFocus rates COCH with a GF Score™ of 6/100 and a GF Value™ of $0.81 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 318 Medical Devices & Instruments companies, Envoy Medical ranks worse than 314465.09% on this metric.

Envoy Medical's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for Envoy Medical's 5-Year Yield-on-Cost % or its related term are showing as below:



COCH's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.355
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Envoy Medical  (NAS:COCH) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Envoy Medical 5-Year Yield-on-Cost % Related Terms


COCH vs ECOR, MDAI, SNWV: 5-Year Yield-on-Cost % Comparison

For the Medical Devices subindustry, Envoy Medical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Envoy Medical 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Envoy Medical's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Envoy Medical's 5-Year Yield-on-Cost % falls into.


COCH
6GF Score
Envoy Medical Inc COCH
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Envoy Medical 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Envoy Medical is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Envoy Medical (COCH) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Envoy Medical and its competitors. According to the industry distribution chart, Envoy Medical ranks #999999 out of 318 companies in the Medical Devices & Instruments industry.
Is Envoy Medical's 5-Year Yield-on-Cost % too high?
Envoy Medical's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Envoy Medical ranks #999999 out of 318 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Envoy Medical has a GF Score™ of 6/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Envoy Medical's 5-Year Yield-on-Cost % compare to ECOR and MDAI?
According to the Medical Devices & Instruments industry distribution chart, Envoy Medical ranks #999999 out of 318 companies for 5-Year Yield-on-Cost %. This places Envoy Medical in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.36, based on 318 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Envoy Medical and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Envoy Medical's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envoy Medical stock overvalued right now?
Based on GuruFocus' analysis, Envoy Medical (COCH) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.81, compared to a current price of $0.67 — trading 17.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Envoy Medical's overall GF Score™ is 6/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Envoy Medical (COCH), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Envoy Medical (COCH) Overvalued in 2026?

Based on GuruFocus' analysis, Envoy Medical stock appears to be undervalued. The current stock price of $0.67 is trading 17.1% below its estimated GF Value™ of $0.81. GuruFocus considers Envoy Medical to be Modestly Undervalued.

Key valuation signals for COCH:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $0.81 vs. price of $0.67 (17.1% below fair value)
  • GF Score™: 6/100 with 6 warning signs

No single metric tells the full story. See the COCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Envoy Medical Business Description

Address 4875 White Bear Parkway, White Bear Lake, MN, USA, 55110
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
6GF Score

Get the complete analysis for COCH

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.67
Price
$0.81
GF Value